Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 72, n° 2
pages 367-368 (février 2015)
Doi : 10.1016/j.jaad.2014.09.056
Notes & Comments

Anal cancer screening
 

Alexander Kreuter, MD a, , Stefan Esser, MD b, Ulrike Wieland, MD c
a Department of Dermatology, Venereology, and Allergology, HELIOS St Elisabeth Hospital Oberhausen, Oberhausen, Germany 
b Department of Dermatology and Venerology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany 
c Institute of Virology, National Reference Center for Polyomaviruses and Papillomaviruses, University of Cologne, Germany 

Correspondence to: Alexander Kreuter, MD, Department of Dermatology, Venereology, and Allergology, HELIOS St Elisabeth Hospital Oberhausen, Josefstrasse 3, 46045 Oberhausen, Germany

 Funding sources: None.
 Disclosures: Dr Kreuter has served as a speaker for Meda Pharma, for which he received honoraria. He also serves on a scientific advisory board of MSD Sanofi Pasteur. Dr Esser takes part as local principal investigator in the Human Papillomavirus Quadrivalent Vaccine Study program of Merck and MSD Sanofi Pasteur. Dr Wieland has no conflicts of interest to declare.


Top of the page

© 2014  American Academy of Dermatology, Inc.@@#104156@@